UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Less common etiologies of exocrine pancreatic insufficiency

World journal of gastroenterology : WJG, 2017-10, Vol.23 (39), p.7059-7076

2017

Volltextzugriff (PDF)

Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Chest, 2012-09, Vol.142 (3), p.718-724

2012

Volltextzugriff (PDF)

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

Journal of cystic fibrosis, 2011-01, Vol.10 (1), p.54-61

2011

Volltextzugriff (PDF)

Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects

Antimicrobial Agents and Chemotherapy, 2011-06, Vol.55 (6), p.2636-2640

2011

Volltextzugriff (PDF)

Differential depth distribution of microbial function and putative symbionts through sediment-hosted aquifers in the deep terrestrial subsurface

Nature microbiology, 2018-03, Vol.3 (3), p.328-336

2018

Volltextzugriff (PDF)

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results

PloS one, 2014-09, Vol.9 (9), p.e106195

2014

Volltextzugriff (PDF)

Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology

Journal of aerosol medicine and pulmonary drug delivery, 2011-08, Vol.24 (4), p.175-182

2011

Volltextzugriff (PDF)

Aerosol Antibiotics in Cystic Fibrosis

Respiratory care, 2009-05, Vol.54 (5), p.658-670

GELLER, David E

2009

Volltextzugriff (PDF)

Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis

Chest, 2002-07, Vol.122 (1), p.219-226

2002

Volltextzugriff (PDF)

The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States

Annals of allergy, asthma, & immunology, 2012-03, Vol.108 (3), p.157-162.e1

2012

Volltextzugriff (PDF)

Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa

American journal of respiratory and critical care medicine, 2011-06, Vol.183 (11), p.1510-1516

2011

Volltextzugriff (PDF)

Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler

Respiratory care, 2005-10, Vol.50 (10), p.1313-21; discussion 1321-2

Geller, David E

2005

Volltextzugriff (PDF)

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial

Pediatric pulmonology, 2011-03, Vol.46 (3), p.230-238

2011

Volltextzugriff (PDF)

Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection

Pediatric pulmonology, 2014-07, Vol.49 (7), p.650-658

2014

Volltextzugriff (PDF)

Efficiency of Pulmonary Administration of Tobramycin Solution for Inhalation in Cystic Fibrosis Using an Improved Drug Delivery System

Chest, 2003-01, Vol.123 (1), p.28-36

2003

Volltextzugriff (PDF)

Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis

Respiratory medicine, 2011-12, Vol.105, p.S24-S31

2011

Volltextzugriff (PDF)

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

American journal of respiratory and critical care medicine, 2012-01, Vol.185 (2), p.171-178

2012

Volltextzugriff (PDF)

Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis: An International Randomized Study

American journal of respiratory and critical care medicine, 2012-03, Vol.185 (6), p.645-652

2012

Volltextzugriff (PDF)

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Journal of cystic fibrosis, 2019-09, Vol.18 (5), p.700-707

2019

Volltextzugriff (PDF)

Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics

Respiratory medicine, 2011-12, Vol.105, p.S2-S8

2011

Volltextzugriff (PDF)

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients

Journal of cystic fibrosis, 2016-07, Vol.15 (4), p.495-502

2016

Volltextzugriff (PDF)

Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system

Pediatric critical care medicine, 2013-06, Vol.14 (5), p.e250-e256

2013

Volltextzugriff (PDF)

New Aerosol Delivery Devices for Cystic Fibrosis

Respiratory care, 2009-06, Vol.54 (6), p.754-768

2009

Volltextzugriff (PDF)

Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety

Pediatric pulmonology, 2007-04, Vol.42 (4), p.307-313

2007

Volltextzugriff (PDF)

Tobramycin inhalation powder in cystic fibrosis patients: response by age group

Respiratory care, 2014-03, Vol.59 (3), p.388-398

2014

Volltextzugriff (PDF)

1 – 25 von 479

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(447)
Mit Volltextzugriff
(377)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Less common etiologies of exocrine pancreatic insufficiency

Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects

Differential depth distribution of microbial function and putative symbionts through sediment-hosted aquifers in the deep terrestrial subsurface

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results

Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology

Aerosol Antibiotics in Cystic Fibrosis

Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis

The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States

Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa

Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial

Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection

Efficiency of Pulmonary Administration of Tobramycin Solution for Inhalation in Cystic Fibrosis Using an Improved Drug Delivery System

Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection

Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis: An International Randomized Study

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients

Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system

New Aerosol Delivery Devices for Cystic Fibrosis

Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety

Tobramycin inhalation powder in cystic fibrosis patients: response by age group

Suchergebnisse filtern